Potentia Wealth’s GSK GSK Stock Holding History

Potentia Wealth’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5,725	Closed	-$316K	–	76
2026 Q1	$316K	Sell	5,725 -673	-11%	-$36.5K	0.12%	75
2025 Q4	$314K	Sell	6,398 -39	-0.6%	-$1.82K	0.12%	78
2025 Q3	$278K	Buy	+6,437	New	+$251K	0.11%	84
2025 Q2	–	Sell	-9,836	Closed	-$381K	–	83
2025 Q1	$381K	Sell	9,836 -1,443	-13%	-$52.8K	0.18%	67
2024 Q4	$381K	Buy	+11,279	New	+$406K	0.17%	71

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Potentia Wealth's GSK Position: Q2 2026 in Review

Potentia Wealth sold out of GSK (GSK) in Q2 2026, closing a stake of 5,725 shares — an estimated $316K sold.

Potentia Wealth first reported a position in GSK in Q4 2024 and held it in 5 quarters. The position peaked at $381K in Q4 2024. 1,045 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Potentia Wealth reported no remaining GSK position as of Q2 2026 after selling out during the quarter.
Potentia Wealth sold 5,725 GSK shares in Q2 2026, an estimated $316K.
Potentia Wealth first reported a position in GSK in Q4 2024 and held it in 5 quarters.
Potentia Wealth's GSK position peaked at $381K in Q4 2024.
1,045 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Potentia Wealth's 13F filing for Q2 2026, filed 13 Aug 2026.